2022-16994. Importer of Controlled Substances Application: Cerilliant Corporation  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2022. Such persons may also file a written request for a hearing on the application on or before September 8, 2022.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on June 30, 2022, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Start Printed Page 48507

    Controlled substanceDrug codeSchedule
    3-Fluoro-N-methylcathinone (3-FMC)1233I
    Cathinone1235I
    Methcathinone1237I
    4-Fluoro-N-methylcathinone (4-FMC)1238I
    Pentedrone (α-methylaminovalerophenone)1246I
    Mephedrone (4-Methyl-N-methylcathinone)1248I
    4-Methyl-N-ethylcathinone (4-MEC)1249I
    Naphyrone1258I
    N-Ethylamphetamine1475I
    N,N-Dimethylamphetamine1480I
    Fenethylline1503I
    Methaqualone2565I
    JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
    SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)7008I
    5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
    AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7012I
    JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
    AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7023I
    THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone)7024I
    AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)7031I
    ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7035I
    APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide)7048I
    JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)7081I
    SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole)7104I
    JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
    JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)7122I
    UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone7144I
    JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
    JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
    AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201I
    JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I
    PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222I
    5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)7225I
    Alpha-ethyltryptamine7249I
    Ibogaine7260I
    CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
    CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I
    Lysergic acid diethylamide7315I
    2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine7348I
    Marihuana7360I
    Parahexyl7374I
    Mescaline7381I
    2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine )7385I
    3,4,5-Trimethoxyamphetamine7390I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    4-Methyl-2,5-dimethoxyamphetamine7395I
    2,5-Dimethoxyamphetamine7396I
    JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I
    3,4-Methylenedioxyamphetamine7400I
    5-Methoxy-3,4-methylenedioxyamphetamine7401I
    N-Hydroxy-3,4-methylenedioxyamphetamine7402I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    4-Methoxyamphetamine7411I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Alpha-methyltryptamine7432I
    Bufotenine7433I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    Psilocybin7437I
    Psilocyn7438I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    N-Ethyl-1-phenylcyclohexylamine7455I
    1-(1-Phenylcyclohexyl)pyrrolidine7458I
    1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
    N-Benzylpiperazine7493I
    4-MePPP (4-Methyl-alphapyrrolidinopropiophenone)7498I
    2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine)7508I
    2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine)7509I
    2C-H 2-(2,5-Dimethoxyphenyl) ethanamine)7517I
    2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine)7518I
    2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine)7519I
    Start Printed Page 48508
    2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine)7521I
    2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine)7524I
    2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine)7532I
    MDPV (3,4-Methylenedioxypyrovalerone)7535I
    25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)7536I
    25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)7537I
    25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)7538I
    Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
    Butylone7541I
    Pentylone7542I
    alpha-pyrrolidinopentiophenone (α-PVP)7545I
    alpha-pyrrolidinobutiophenone (α-PBP)7546I
    AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I
    Desomorphine9055I
    Etorphine (except HCl)9056I
    Codeine methylbromide9070I
    Heroin9200I
    Morphine-N-oxide9307I
    Normorphine9313I
    Pholcodine9314I
    U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547I
    AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))9551I
    Acetylmethadol9601I
    Allylprodine9602I
    Alphacetylmethadol except levo-alphacetylmethadol9603I
    Alphameprodine9604I
    Alphamethadol9605I
    Betacetylmethadol9607I
    Betameprodine9608I
    Betamethadol9609I
    Betaprodine9611I
    Dextromoramide9613I
    Dipipanone9622I
    Hydroxypethidine9627I
    Noracymethadol9633I
    Norlevorphanol9634I
    Normethadone9635I
    Racemoramide9645I
    Trimeperidine9646I
    1-Methyl-4-phenyl-4-propionoxypiperidine9661I
    Tilidine9750I
    Para-Fluorofentanyl9812I
    3-Methylfentanyl9813I
    Alpha-methylfentanyl9814I
    Acetyl-alpha-methylfentanyl9815I
    Beta-hydroxyfentanyl9830I
    Beta-hydroxy-3-methylfentanyl9831I
    Alpha-methylthiofentanyl9832I
    3-Methylthiofentanyl9833I
    Thiofentanyl9835I
    Fentanyl related-compounds as defined in 21 CFR 1308.11(h)9850I
    Methamphetamine1105II
    Methylphenidate1724II
    Amobarbital2125II
    Pentobarbital2270II
    Secobarbital2315II
    Glutethimide2550II
    Nabilone7379II
    1-Phenylcyclohexylamine7460II
    Phencyclidine7471II
    Phenylacetone8501II
    1-Piperidinocyclohexanecarbonitrile8603II
    Alphaprodine9010II
    Dihydrocodeine9120II
    Ecgonine9180II
    Ethylmorphine9190II
    Levomethorphan9210II
    Levorphanol9220II
    Meperidine9230II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    Levo-alphacetylmethadol9648II
    Noroxymorphone9668II
    Racemethorphan9732II
    Start Printed Page 48509
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Carfentanil9743II
    Tapentadol9780II

    The company plans to import the listed controlled substances for the manufacturing of analytical reference standards and distribution to their research and forensic customers. No other activities for these drug codes are authorized for this registration.

    Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.

    Start Signature

    Kristi O'Malley,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2022-16994 Filed 8-8-22; 8:45 am]

    BILLING CODE P

Document Information

Published:
08/09/2022
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2022-16994
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before September 8, 2022. Such persons may also file a written request for a hearing on the application on or before September 8, 2022.
Pages:
48506-48509 (4 pages)
Docket Numbers:
Docket No. DEA-1052
PDF File:
2022-16994.pdf
Supporting Documents:
» Importer Application - Cerilliant Corporation (2022-16994) - DEA1052